Nutriband
NTRB
11 hedge funds and large institutions have $505K invested in Nutriband in 2023 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 4 reducing their positions, and 0 closing their positions.
10% more funds holding
Funds holding: 10 → 11 (+1)
0.06% more ownership
Funds ownership: 2.5% → 2.57% (+0.06%)
14% less capital invested
Capital invested by funds: $588K → $505K (-$82.9K)
75% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$26.2K |
| 2 |
JP Morgan Chase
New York
|
+$20 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TRCT
Tower Research Capital (TRC)
New York
|
-$6.74K |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
-$2.91K |
| 3 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$20 |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$10 |
NTRB Hedge Fund Activity: Q3 2023 in Review
11 of the 6,302 institutional investors tracked by Wall St. Rank reported a position in Nutriband (NTRB) for Q3 2023, worth a combined $505K — down 14% from $588K a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new NTRB positions and 0 closed out — a net gain of 1 holder — while 1 added to existing stakes and 4 trimmed.
The largest buyer was Vanguard Group, adding an estimated $26.2K. The largest seller was Tower Research Capital (TRC), cutting an estimated $6.74K.
- 11 institutional investors held Nutriband (NTRB) as of Q3 2023, up from 10 in Q2 2023.
- Funds reported $505K of Nutriband stock for Q3 2023, down 14% quarter-over-quarter.
- 1 fund opened new Nutriband positions in Q3 2023 and 0 closed out, a net change of +1 holder.
- The largest Nutriband buyer in Q3 2023 was Vanguard Group, an estimated $26.2K added.
- The largest Nutriband seller in Q3 2023 was Tower Research Capital (TRC), an estimated $6.74K sold.
Based on aggregated 13F filings for Q3 2023.